Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 2/16/2022
How long does protection last after three doses of mRNA COVID-19 vaccine?
Study examines vaccine effectiveness among U.S. adults after two and three doses of vaccine during periods of Delta and Omicron variant predominance. - 2/14/2022
Spironolactone not associated with a significant increase in cancer risk
Systematic review and meta-analysis finds no substantial increased risk of cancer with spironolactone, and a decreased risk of prostate cancer. - 2/9/2022
Ketamine may be useful for acute treatment of severe suicidal ideation
Study finds ketamine to be a safe, rapidly effective treatment for suicidal crisis in patients with bipolar disorder. - 2/8/2022
Pop quiz: Pharmacy professionals in the Olympics
Go Canada! Canadian pharmacists have taken their place in Olympic history. - 2/7/2022
Updated Canadian guidelines on sexually transmitted and blood-borne infections
Provide guidance for healthcare providers and public health professionals on the prevention and management of sexually transmitted and blood-borne infections - 2/3/2022
Scope of practice change will allow point-of-care testing in Ontario pharmacies
Ontario provincial government regulatory amendment will take effect July 1, 2022. - 2/2/2022
Canadian study ranks efficacy of various treatments for male pattern baldness
Meta-analysis examines relative efficacy of oral and topical minoxidil, oral dutasteride and oral finasteride for male androgenetic alopecia. - 1/31/2022
Bladder Cancer Canada addresses resolution of BCG shortage for bladder cancer
Patients with nonmuscle-invasive bladder cancer should receive full doses of BCG. - 1/30/2022
Pop quiz: Paxlovid drug interactions
All of the following medications are contraindicated concomitantly with Paxlovid (nirmatrelvir/ritonavir), EXCEPT for . . . - 1/30/2022
Schedule I and II natural health products removed from national drug schedules
Final two Natural Health Products, ephedrine and pseudoephedrine, will be delisted in early 2024.
